Follow-The-Filings

Security · featured owners

CRVS Corvus Pharmaceuticals Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.2%
  • $1M
  • 1 reduce

CRVS (Corvus Pharmaceuticals Inc.) is held in 1 featured 13F book as of 2026 Q2. David Witzke - Avidity Partners Management is the largest tracked holder by portfolio weight (0.19%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.2% (David Witzke - Avidity Partners Management) · not free-float ownership

  1. David Witzke reduce 0.19%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
David Witzke - Avidity Partners Management 2026 Q2 0.19% Reduce −30.4% 80,000 $1M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 23 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
424B5 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 8 rows shown

Filed Form Detail Links
4 Period Jun 11, 2026 · 5 forms Filing Doc
4 Period May 18, 2026 Filing Doc
4 Period Apr 23, 2026 Filing Doc
4 Period Jan 28, 2026 Filing Doc
4 Period Dec 4, 2025 · 4 forms Filing Doc
4 Period Oct 2, 2025 Filing Doc
4 Period Jun 27, 2025 · 2 forms Filing Doc
4 Period Jun 12, 2025 · 2 forms Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$27.03M -$62.29M -$15.28M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $27.96M $54.41M $58.21M
Total non-current assets * $17.6M $14.5M $12.9M
Total assets $45.55M $68.91M $71.12M
Total current liabilities $6.87M $35.4M $9.38M
Total non-current liabilities * $0.00 $937,000 $534,000
Total equity $38.68M $32.57M $61.2M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$23.94M -$25.42M -$32.8M
Cash from investing $15.54M -$27.48M -$7.8M
Cash from financing $7.86M $49.03M $36.43M
Net change in cash -$0.539M -$3.88M -$4.16M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders